樱花视频

Skip to main content
  • Research
  • Published:

Association between population viral load surrogate indicator and HIV transmission potential: a prospective cohort study in Xinjiang, China

Abstract

Background

New indicators of potential human immunodeficiency virus (HIV) transmission are being actively explored. We aim to categorical testing of the viral load (VL) of persons living with HIV听(PLWH) in order to explore new indicators to measure the intensity of the epidemic and the effectiveness of the response in the community.

Methods

A dynamic cohort study was conducted in Yining to monitor the VL of all persons living with HIV from 2017 to 2019. Different population VL (PVL) surrogate indicators were measured and the strength of the associations of different PVL surrogates with HIV incidence, antiretroviral therapy (ART) coverage, virus unsuppression, and viremia prevalence was assessed. PVL surrogate indicators were used to describe the current status of HIV transmission in different populations and communities.

Results

All PVL indicators decreased from 2017 to 2019 (P鈥<鈥0.05). Arithmetic mean community viral load (CVL) (r鈥=鈥1.000, P鈥=鈥0.006) and geometric mean CVL (r鈥=鈥1.000, P鈥=鈥0.001) were positively associated with HIV incidence, ART coverage and viral unsuppression (P鈥<鈥0.05). CVL was higher in the male, 鈮も25 years of age, primary school or below, other household registration, other medical insurance types, other source of sample, nonmarital and noncommercial heterosexual contact, and nonmarital and commercial heterosexual contact subgroups. Community-based cross-sectional analyses showed that CVL in community 10 was positively correlated with viral unsuppression rate and viremia prevalence but negatively correlated with ART coverage rate, suggesting that the community was a hotspot for HIV epidemics.

Conclusions

CVL can be used as an indicator for assessing HIV transmission and identifying high-risk populations and hotspot communities.

Peer Review reports

Introduction

The epidemiology and modes of transmission of human immunodeficiency virus (HIV) have changed dramatically over the past few decades, and interventions for preventing HIV transmission are constantly being explored and updated [1]. In recent years, acquired immunodeficiency syndrome (AIDS) prevention worldwide has been based on the Treatment as Prevention strategy, in which patients receive antiretroviral therapy (ART) at an early stage to control viral load (VL) and achieve viral suppression, thereby reducing the risk of HIV transmission [2,3,4]. Previous HIV prevention and treatment efforts have focused more on individual VL monitoring, and ART has been shown to reduce individual HIV VL and transmission [5]. Theoretically, higher ART coverage in the community should lead to lower total and average population VL (PVL), higher viral suppression rate, and lower HIV transmission in the community. HIV VL, which objectively reflects the level of HIV replication in the body, is a major factor affecting HIV transmission [6,7,8]. The incidence of HIV infections serves as a better indicator for the current epidemiological status of the disease and is crucial for monitoring HIV transmission and control. However, the incidence of infection is difficult and time-consuming to measure and is somewhat limited by the need for frequent testing of entire populations [9].

PVL or community viral load (CVL) has been proposed as an indicator for HIV incidence [10, 11]. Arithmetic mean or geometric mean PVL is an indicator for HIV transmission in a particular geographic region or population during a specific period of time [12, 13]. However, accurate measurement of PVL indicators is challenging due to undiagnosed cases, confirmed but untreated cases, cases with undetectable VL under treatment, and individuals who are unaware of their VL status. The US CDC guidelines for CVL [11], Solomon et al. [14] and Jiang et al. [15] have proposed 4 realistic and feasible surrogate indicators for PVL based on different levels of PVL monitoring, including monitored viral load (MVL), in-care viral load (ICVL), aware viral load (AVL), and CVL. CVL has been recognized in several studies as an important indicator for evaluating the risk of HIV transmission in a population or region [11, 14, 16]. Das et al. [17] showed that mean CVL was correlated with HIV incidence in San Francisco. A Colombian study [18] reported strong correlations among increased ART coverage, decreased PVL, and decreased number of new HIV cases. A study of injected drug users in San Francisco indicated that mean CVL was significantly associated with HIV incidence [19], validating the utility of CVL as a measure of HIV transmission. Furthermore, we have conducted a preliminary analysis focusing on the temporal aspect of the substitution effect of geometric CVL for PVL, and the initial findings were quite encouraging [20].

So far, there have been few studies in China that directly compare the VL monitoring levels among different populations and jointly analyze the strength of the association between PVL surrogate indicators and HIV transmission from both temporal and spatial perspectives. Xinjiang is one of the regions with the highest HIV incidence in China [21]. Therefore, it is particularly important to reduce the persistently high rate of HIV transmission in the population as early as possible, to implement targeted interventions for key populations, and to rationally allocate financial and human resources. The current state of knowledge regarding the HIV transmission potential in Yining City, Xinjiang is limited, and the present study aims to explore the association between PVL proxy indicators and HIV transmission potential through a cohort study. The objective is to identify new and convenient indicators, with the aim of better identifying the key HIV populations and communities in the region. This will help to set up a targeted HIV prevention and control programme and reduce the HIV transmission potential.

Methods

Subjects and test parameters

We established a prospective cohort to expand VL testing in Yining City, Xinjiang. The cohort started on January 1, 2017. Informed consenting persons living with HIV (PLWH) aged 13 years or older from the Yining City HIV outbreak pool were recruited as study participants, including both treated and untreated individuals, as well as those with newly reported HIV infection in the current year. The inclusion criteria were as follows: (a) HIV confirmatory test positive; (b) current address in Yining City, Xinjiang, China; (c) age鈥夆墺鈥13 years; (d) informed consent. Exclusion criteria: those who did not meet the inclusion criteria. Following the recruitment of subjects and the acquisition of informed consent (for participants under 18 years of age, informed consent was required from both the subjects and their guardians), laboratory tests and questionnaires were administered. The questionnaires collected baseline information, HIV testing status, antiretroviral therapy (ART) status, previous immunological and virological history, behavioral data, and clinical information. Laboratory tests and questionnaires were administered annually and prospectively followed for three years, collecting data on newly reported HIV infections each year. The on-site follow-up concluded on 31 December 2019.

The cohort follow-up was based on routine HIV testing, with grassroots staff responsible for the accurate monitoring of HIV-infected patients. The baseline status of PLWH was categorized as follows: patients on treatment, who were sampled annually at sentinel hospitals for VL and CD4 testing; patients not on treatment, who were sampled annually at local Centers for Disease Control and Prevention (CDC) for CD4 testing; and newly reported HIV infections within the same surveillance and testing population, who underwent testing for new infections, as well as VL and CD4 testing following diagnosis. Follow-up visits and laboratory testing were conducted in accordance with the classification status of PLWH. Among these, newly reported HIV-infected individuals were classified as treated or untreated based on their engagement with ART. Treated individuals were followed up by the outpatient physicians they regularly consulted, while untreated individuals received regular follow-up from local CDC staff. All study participants completed a questionnaire, which was filled out by their follow-up physician or CDC staff, designed with reference to the national sentinel surveillance questionnaire. The outpatient doctors and local CDC staff were researchers at the study sites, with whom the group had established long-term collaborations. Prior to the commencement of the study, standardized training was organized centrally for the staff at each site, and appropriate compensation was provided to ensure high-quality completion of the follow-up work.

Laboratory tests

VL in blood samples was measured using the COBAS TaqMan HIV-1 test v2.0 HIV-1 kit (Roche) on an automated instrument (Roche COBAS AmpliPrep COBAS TaqMan48). HIV screening was performed using an HIV ELISA diagnostic kit (Invitrogen). Subjects who were positive at initial screening were retested using the HIV antibody ELISA diagnostic kit from Beijing Jinhao. All samples (including positive and negative samples) were stored for at least 12 months after the end of study.

Indicator definition and calculation

VL monitoring indicators

According to the CVL guidelines published by the US CDC [11] and findings of Solomon et al. [14] and Jiang et al. [15], VL surveillance indicators of different populations were defined as follows: (1) MVL: VL of subjects currently on treatment and surveillance; (2) ICVL: VL of subjects receiving therapy regardless of monitoring; (3) AVL: VL if subjects who were aware of their own VL status, regardless of treatment; (4) CVL: VL of subjects on treatment and those with confirmed infection but untreated.

Different VL metrics

The limit of VL detection in this study was 20 copies/mL, and all VL values below the limit of detection were documented as 10 copies/mL. The VL measures assessed were total VL, mean VL, and geometric mean VL. Median VL has been used as a VL index in previous studies [6, 11, 12] but was not selected for this study due to its value being lower than the limit of detection (10 copies/mL) in the population. (1) Total VL: Sum of VLs of all HIV/AIDS cases (copies/mL); (2) Mean VL: the sum of VL of all HIV/AIDS cases divided by the total number of HIV cases (copies/mL); (3) Geometric mean VL: VL of all HIV/AIDS cases were log transformed (base 10 logarithm), then summed and divided by the total number of HIV cases (log10 copies/mL).

Indicator definitions

(1) Viral unsuppression was defined as VL鈥夆墺鈥1000 copies/mL; Viral suppression was defined as VL鈥<鈥1000 copies/mL. (2) ART coverage was defined as the number of ART cases/total number of HIV cases 脳 100%. (3) Virus unsuppression rate was defined as the number of virus unsuppression/total number of HIV cases 脳 100% ; Viral suppression rate was defined as the number of VL suppression/total number of HIV cases 脳 100%. (4) Viremia prevalence was defined as the number of cases with VL鈥>鈥20 copies/mL/total number of HIV cases 脳 100%. (5) We estimated the rate of new HIV infections in the entire population of Yining City by utilizing annual data on testing for recent infections. To estimate HIV incidence, we employed the HIV incidence estimation formula proposed by McWalter and Welte (2010) [22,23,24,25,26]. The HIV incidence rate was calculated as: \(Ir = \frac{{R - \varepsilon P}}{{(1 - \varepsilon )\omega N}}\), N鈥=鈥塶umber of HIV-negative subjects; P鈥=鈥塶umber of PLWH; R鈥=鈥塶umber of new infections; 蠅鈥=鈥塎ean time to new infection; 蔚鈥=鈥塮alse reject rate for new infections. HIV incidence in this study was estimated based on the values (蠅鈥=鈥130d, 蔚鈥=鈥2.3%) provided by the ELISA kit (Jinhao, Beijing).

Statistical analysis

Time-based analysis

Sensitivity analysis: There were 55 subjects with missing VL values, which was lower than the maximum allowable limit (25%). Missing values were imputed using the Markov Chain Monte Carlo (MCMC) [27] algorithm in SPSS 22.0, and indicators with missing VL value were analyzed before and after imputation. In addition, sensitivity analysis was performed on the distribution of subjects with and without missing VL (Table S1). Measurement data were compared between groups using the Wilcoxon rank sum test in SPSS 22.0. A P鈥<鈥0.05 was considered statistically significant. Graphs were plotted using GraphPad Prism 8.3.0.

Geo-community-based analysis

Yining has 9 townships, 8 sub-district offices, and 4 districts (1 economic zone and 3 field districts), totaling 21 community units (collectively referred to as communities). Considering that the 2018 data had the lowest number of missing VL and were obtained from a large cohort, the cross-sectional analysis was performed on the 2018 data. One of the communities did not have an existing HIV infection, and hence only 20 communities (communities 1 to 20) were included in this analysis. PVL-related indicators were selected as the best indicators in the longitudinal-based analysis.

Data from the 20 communities were collated and analyzed, and the lollipop chart were generated using R4.3.0. Correlation analysis was performed using the Pearson鈥檚 correlation coefficient for data with normal distribution and the Spearman鈥檚 rank correlation coefficient for data without normal distribution. Association among viral unsuppression rate, viremia prevalence, untreated rate and CVL was determined using linear regression. The adjusted R2 represented the proportion of variance explained by the covariate and was used to evaluate the advantages and disadvantages of the model. Model fitting was done using the Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) [28]. A P鈥<鈥0.05 was considered statistically significant.

Results

Demographic characteristics of PLWH in Yining between 2017 and 2019

A total of 3920, 4167, 4080 subjects were monitored in 2017, 2018, and 2019, respectively. There was no change in the distribution trends of sex and routes of transmission between 2017 and 2019 (P鈥>鈥0.05). HIV infection was more prevalent in males, and the routes of transmission were mainly injected drugs, non-marital and non-commercial heterosexual contact, and Positive for spouse/fixed partner. Age, education level, household registration and medical insurance type of the surveyed subjects were significantly different across the 3 years (P鈥<鈥0.05). Our data showed that HIV infection was most common at the age of 36鈥45 years, followed by 46鈥55 years, which indicates that HIV infection is becoming increasingly prevalent at an advanced age. The education level of the subjects was mainly primary school or below, and most subjects had a household registration in urban areas. The main types of medical insurance were social insurance and new rural cooperative medical insurance (Table 1).

Table 1 Distribution of general demographic characteristics of PLWH in Yining from 2017 to 2019

Comparison of different PVL monitoring indicators for 2017鈥2019

Total VL, mean VL, and geometric mean VL were calculated separately for MVL, ICVL, AVL, and CVL. There was a significant annual decrease in different VL values (total VL, mean VL, and geometric mean VL) for each PVL indicator (P鈥<鈥0.05). In particular, CVL was higher than MVL, ICVL, and AVL in all 3 years (Table 2).

Since there were missing values for AVL and CVL, sensitivity analyses were performed to determine the robustness of the results before and after imputation. Our results showed slightly higher values after imputation, but the difference was not statistically significant (Table S2).

Table 2 Comparison of VL monitoring indicators for different populations from 2017 to 2019

Correlation between different PVL monitoring indicators and HIV incidence

The incidence of HIV was 0.002685% in 2017, 0.002252% in 2018, and 0.001246% in 2019, showing a trend of annual decrease. MVL, ICVL, AVL, and CVL were decreased from 2017 to 2019, but only the decrease in CVL was correlated with the decrease in the incidence of HIV. Only mean CVL (r鈥=鈥1.000, P鈥=鈥0.006) and geometric mean CVL (r鈥=鈥1.000, P鈥=鈥0.001) were positively correlated with HIV incidence (Fig. 1). Sensitivity analyses of imputed missing VL values yielded the same results as above for mean CVL* (r鈥=鈥1.000, P鈥=鈥0.003) and geometric mean CVL* (r鈥=鈥0.999, P鈥=鈥0.028) (Figure S1).

Fig. 1
figure 1

Trends in different PVL indicators and HIV incidence between 2017 and 2019

Correlation of different PVL indicators and ART coverage, viral unsuppression rate, and viremia prevalence

ART coverage increased from 74.01 to 87.04% (P鈥<鈥0.001), viral unsuppression rate decreased from 35.56 to 23.58% (P鈥<鈥0.001), and viremia prevalence decreased from 47.35 to 23.58% (P鈥<鈥0.001) in the overall population from 2017 to 2019. These results indicated an overall better HIV status in the city. Sensitivity analyses showed that the PVL indicators changed after imputation of missing values, with ART coverage increasing from 74.06 to 87.11% (P鈥<鈥0.001), viral unsuppression rate decreasing from 35.61 to 23.63% (P鈥<鈥0.001), and viremia prevalence decreasing from 47.60 to 36.89% (P鈥&濒迟;鈥0.001).

Correlation analysis revealed a significant association of HIV incidence with ART coverage and viral unsuppression rate (P鈥<鈥0.05). In addition, arithmetic mean and geometric mean CVL were significantly associated with ART coverage and viral unsuppression rate (P鈥<鈥0.05) (Table 3). Sensitivity analysis indicated that the results were robust (Table S3). Taken together, arithmetic mean CVL and geometric mean CVL are better surrogates for PVL for describing the overall HIV transmission in the region.

Table 3 Correlation of PVL indicators with ART coverage, viral unsuppression rate and viremia prevalence

Comparison of CVL between different treatment, viral suppression, and viremia statuses

CVL was significantly different between treatment statuses, viral suppression statuses, and viremia statuses (P鈥<鈥0.05). In addition, CVL was significantly different across the 3 years in all groups except in the viral suppression group (P鈥<鈥0.05) (Table 4). Sensitivity analysis indicated that the results were stable (P鈥>鈥0.05) (Figure S2 and Table S4).

Table 4 Comparison of CVL between ART, viral suppression and viremia statuses

Comparison of CVL in the general population between 2017 and 2019

We selected the pre-imputation data for this analysis as there was no significant difference in population distribution before and after imputation for missing VL values. A comparison of CVL values showed significant decrease in sex, age, education level, and medical insurance type (P鈥<鈥0.05) in 2019 compared with 2017. Furthermore, CVL was significantly different among subgroups of each demographic characteristic (P鈥<鈥0.001) except for medical insurance types (P鈥>鈥0.05). In particular, CVL was higher in men, 鈮 25 years old, primary school or below, other household registration place, other medical insurance types, other sample sources, nonmarital and noncommercial heterosexual contacts, and nonmarital and commercial heterosexual contacts (Table 5).

Table 5 Comparison of CVL in the general population between 2017 and 2019

Distribution of CVL, ART coverage, viral unsuppression rate, and viremia prevalence by community in Yining

Cross-sectional analysis of the 20 communities in 2018 showed that the CVL, ART coverage, viral unsuppression rate and viremia prevalence ranged from 1.64 to 2.49 log10 copies/mL (median 2.18 log10 copies/mL), 68.21鈥89.47% (median 78.51%), 15.79鈥39.74% (median 30.35%), and 21.05鈥56.90% (median 44.53%), respectively. Community 10 had the highest CVL and viral unsuppression rate, lowest ART coverage, and second lowest viremia prevalence after community 6 (Fig. 2). On the other hand, community 18 had the lowest CVL, viral unsuppression rate and viremia prevalence as well as the highest ART coverage. There was a positive correlation among CVL, viral unsuppression rate and viremia prevalence, and a negative correlation between ART coverage and the other three indicators (Figure S3).

Fig. 2
figure 2

Distribution of CVL, ART coverage, viral unsuppression rate, and viremia prevalence in various communities of Yining

Linear regression of CVL with viral unsuppression rate, viremia prevalence, and ART coverage

Linear correlation analysis and regression estimation showed that viral unsuppression rate had the strongest correlation with CVL (R2 adj: 0.982, AIC/BIC: -80.91/-77.92), with each one-unit increase associated with a 0.036 log10 copies/mL increase in CVL (95% CI: 0.033鈥鈥0.038), followed by viremia prevalence and ART coverage in the 20 communities (Table 6).

Table 6 Linear regression analysis of CVL with ART coverage, viral unsuppression rate and viremia prevalence

Discussion

Our study found that PVL indicators decreased annually in Xinjiang, which were consistent with findings reported in other countries [29, 30]. Although the PVL surrogate indicators MVL, ICVL, AVL, CVL, including their total VL, mean VL, and geometric mean VL, showed the same trend of change in HIV incidence, only CVL was positively associated with HIV incidence. Furthermore, we found that HIV incidence was significantly correlated with ART coverage, viral unsuppression rate, while arithmetic mean CVL, geometric mean CVL, and mean ICVL were strongly correlated with ART coverage and viral unsuppression rate.

Arithmetic mean CVL and geometric mean CVL are better PVL surrogate indicators for measuring HIV transmission and burden in the Xinjiang population, which is in line with findings from India [14], South Carolina [30], and Rhode Island [31], and confirms the hypothesis that the increase in ART coverage is linked to decreased viral unsuppressio rate, CVL and HIV incidence. However, Solomon et al. [14] reported that other PVL indicators were also correlated with HIV incidence, albeit the values were lower than CVL. This discrepancy may be related to the included population size for different PVL indicators in this study. In our study, the MVL population largely coincided with the ICVL population, which consisted of subjects with suppressed or undetectable VL and slow VL decline over the 3-year period. In previous studies [14, 18, 32], MVL and ICVL have been used to monitor VL in the on-treatment population, the easy observation of personnel and availability of data allowed the use of MVL and ICVL as surrogate PVL indicators to monitor HIV transmission potential in most studies [11]. However, both indicators are not applicable to the confirmed but untreated cohort, which consists of individuals with high VL [33], thus the PVL is prone to underestimation. Although AVL covers a portion of the untreated population on the basis of MVL and ICVL surveillance populations, population coverage is still inadequate as not all diagnosed persons are aware of their VL. We found that CVL was higher than MVL, ICVL, and AVL in 2017鈥2019. CVL is a more comprehensive and representative estimate of PVL, encompassing all populations in whom PVL can be monitored (those who are undiagnosed cannot be monitored), including untreated individuals. This is in agreement with the US CDC guidelines for CVL [11] and the studies by Rozhnova et al. [34] and Farahani et al. [35]. Therefore, we believe that CVL is a better indicator of monitoring HIV transmission and burden in the population compared with other PVL surrogate indicators.

Enhanced VL surveillance, along with comprehensive utilization of VL data, facilitates the transition from monitoring individual VL to PVL, which transforms PVL from a mere observational parameter of the epidemic into an actionable indicator for improving HIV disease burden [33]. Based on the above results, we selected arithmetic mean CVL and geometric mean CVL to quantify HIV burden in Yining in order to identify the HIV hotspot populations. We found that CVL was relatively high in the male, 鈮 25 years old, primary school or below, other household registration place, other medical insurance types, other sample sources, non-married and commercial heterosexual contacts, and non-married commercial heterosexual contacts subgroups. Targeted interventions should be implemented with respect to individuals with these characteristics, with the aim of effectively lowering HIV burden in the population.

Viremia prevalence adjusted for the number of HIV-negative individuals was proposed by Solomon et al. [14] as a better indicator for HIV transmission. However, we only found an association between total CVL and viremia prevalence but not HIV prevalence, ART coverage or virus unsuppression rate, suggesting that caution should be taken when using this indicator for monitoring HIV burden in communities in Xinjiang. In addition, it is important to note that the VL threshold used to define viremia differed among studies, such as 20 copies/mL in our study compared to 150 copies/mL in the study by Patel et al. [36]. Sensitivity analysis should be performed in future studies to determine the impact of different VL thresholds on the results within the same sample.

To analyse the burden of HIV disease and the effectiveness of HIV prevention and treatment in each community based on geographic communities. By observing the distribution of HIV-related indicators in each community, we can intuitively identify 鈥渉otspot communities鈥 that require more attention, accurately locate the high CVL community, and measure the HIV epidemic status in the city. HIV hotspot communities are important for large-scale intervention in the future [37] as they can be used to predict the risk of infection in HIV-negative individuals and the potential of sustained HIV transmission [38, 39]. This study supports the use of CVL for the geographical identification of high VL populations and hotspot communities as well as underscores the necessity of expanding HIV testing within these communities and populations in order to discover new infections and facilitate effective epidemic monitoring. Integrating geospatial analysis into routine public health planning will enable interventions to be targeted at specific geographical areas, maximizing epidemiological impact and ensuring efficient resource allocation. This approach also allows for a more nuanced assessment of the effectiveness of HIV treatments.

Several limitations should be noted in this study. First, HIV transmission was analyzed without taking into account the impact of HIV prevalence and behavior of the population. For example, in different populations with the same CVL, those with higher HIV prevalence and incidence of high-risk behaviors are likely to have higher HIV transmission [13]. Based on this, we analyzed the CVL of different characteristic populations. Second, the duration of our longitudinal analysis was relatively short and the change in viremia prevalence was small. Therefore, future CVL studies with extended follow-up time and attention to HIV prevalence and high-risk behaviors will be better suited for analyzing the HIV epidemic and assessing the effectiveness of prevention and treatment efforts at the population level. Additionally, we were unable to produce a visualization map for each indicator due to the irregular shape of community distributions and the presence of individual communities composed of multiple, non-contiguous regions. This complexity resulted in suboptimal visualizations. To address this limitation, we opted to represent the higher levels of each indicator using a lollipop chart.

Taken together, our findings suggest that CVL is an effective indicator for assessing the risk of HIV transmission and reflects the potential for HIV transmission in the population. It can be used to dynamically monitor the HIV epidemic and assess the effectiveness of HIV prevention and treatment measures. Currently, the CVL in Yining has decreased annually, affirming the effectiveness of the current prevention and control efforts.

Conclusions

CVL can be used as an indicator for evaluating HIV transmission and the effectiveness of HIV interventions in a population. Efforts should be dedicated to the development of targeted interventions for key populations and hotspot communities to reduce HIV transmission and burden.

Data availability

The data that supports the findings of this study is available from the corresponding author upon reasonable request.

Abbreviations

HIV/AIDS:

Human Immunodeficiency Virus /Acquired Immune Deficiency Syndrome

ART:

Antiretroviral therapy

VL:

Viral load

CVL:

Community viral load

PVL:

Population viral load

MVL:

Monitored viral load

ICVL:

In-care viral load

AVL:

Aware viral load

PLWH:

Persons living with HIV

References

  1. Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou S-S, Zhang XC, et al. Treatment as Prevention: characterization of Partner infections in the HIV Prevention trials Network 052 Trial. JAIDS J Acquir Immune Defic Syndr. 2017;74:112鈥6.

    CAS听 听 听

  2. Oldenburg CE, B盲rnighausen T, Tanser F, Iwuji CC, De Gruttola V, Seage GR, et al. Antiretroviral therapy to prevent HIV Acquisition in Serodiscordant couples in a Hyperendemic Community in Rural South Africa. Clin Infect Dis. 2016;63:548鈥54.

    听 听 听 听

  3. Riddell J, Amico KR, Mayer KH. HIV Preexposure Prophylaxis: a review. JAMA. 2018;319:1261.

    听 听 听

  4. Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, et al. Public health and international drug policy. Lancet. 2016;387:1427鈥80.

    听 听 听 听

  5. Tanser F, B盲rnighausen T, Grapsa E, Zaidi J, Newell M-L. High Coverage of ART Associated with decline in risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa. Science. 2013;339:966鈥71.

    CAS听 听 听 听

  6. Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321:451.

    听 听 听

  7. Shoko C, Chikobvu D. Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa. Theor Biol Med Model. 2018;15:10.

    听 听 听 听

  8. Hendrickx DM, Delva W, Hens N. Influence of sexual risk behaviour and STI co-infection dynamics on the evolution of HIV set point viral load in MSM. Epidemics. 2021;36:100474.

    CAS听 听 听

  9. Okano JT, Gerstoft J, Obel N, Blower S. HIV elimination and population viral load. Lancet HIV. 2016;3:e507鈥9.

    听 听 听 听

  10. Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13:459鈥64.

    听 听 听 听

  11. Centers for Disease Control and Prevention. Guidance on community viral load: a family of measures, definitions, and method for calculation. . Accessed 24 Jul 2023.

  12. Tanser F, Vandormael A, Cuadros D, Phillips AN, De Oliveira T, Tomita A, et al. Effect of population viral load on prospective HIV incidence in a hyperendemic rural African community. Sci Transl Med. 2017;9:eaam8012.

    听 听 听 听

  13. Herbeck J, Tanser F. Community viral load as an index of HIV transmission potential. Lancet HIV. 2016;3:e152鈥4.

    听 听 听

  14. Solomon SS, Mehta SH, McFall AM, Srikrishnan AK, Saravanan S, Laeyendecker O, et al. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study. Lancet HIV. 2016;3:e183鈥90.

    听 听 听 听

  15. Jiang Z, Dou Z, Yan Z, Song W. Effect of data missing on population based viral load survey in HIV infected men who have sex with men sampled in 16 large cities, China. Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38:1169鈥73.

    CAS听 听 听

  16. Krentz HB, Gill MJ. The Effect of Churn on Community viral load in a well-defined Regional Population. JAIDS J Acquir Immune Defic Syndr. 2013;64:190鈥6.

    听 听 听

  17. Das M, Chu PL, Santos G-M, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in Community viral load are accompanied by reductions in New HIV infections in San Francisco. PLoS ONE. 2010;5:e11068.

    听 听 听 听

  18. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376:532鈥9.

    听 听 听 听

  19. Glasheen C, Johnson EO, Lorvick J, Kral AH. Measures of human immunodeficiency virus (HIV) community viral load and HIV incidence among people who inject drugs. Ann Epidemiol. 2018;28:8鈥12.

    听 听 听

  20. Qian HE, Aizimaiti路Aikebaier, Xiao-min HU. Community viral load 鈥 an optimal alternative index of population viral load for HIV/AIDS surveillance. Chin J Public Health. 2022;38:766鈥70.

  21. Bao Y, Larney S, Peacock A, Colledge S, Grebely J, Hickman M, et al. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: a systematic review and meta-analysis. Int J Drug Policy. 2019;70:87鈥93.

    听 听 听 听

  22. Welte A, McWalter TA, B盲rnighausen T. A simplified formula for Inferring HIV incidence from cross-sectional surveys using a test for recent infection. AIDS Res Hum Retroviruses. 2009;25:125鈥6.

    听 听 听 听

  23. McWalter TA, Welte A. A comparison of Biomarker based incidence estimators. PLoS ONE. 2009;4:e7368.

    听 听 听 听

  24. Kassanjee R, Welte A, Otwombe K, Jaffer M, Milovanovic M, Hlongwane K, et al. HIV incidence estimation among female sex workers in South Africa: a multiple methods analysis of cross-sectional survey data. Lancet HIV. 2022;9:e781鈥90.

    CAS听 听 听 听

  25. Welte A, McWalter TA, Laeyendecker O, Hallett TB. Using tests for recent infection to estimate incidence: problems and prospects for HIV. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2010;15.

  26. Szwarcwald CL, Ferreira O, da Brito C, Luhm AM, Ribeiro KR, Silva CEL. Estimation of HIV incidence in two Brazilian municipalities, 2013. Rev Sa煤de P煤blica. 2016;50:55.

    听 听 听 听

  27. A脽mann C, Gaasch J-C, Stingl D. Psychometrika. 2022. . A Bayesian Approach Towards Missing Covariate Data in Multilevel Latent Regression Models.

  28. Dziak JJ, Coffman DL, Lanza ST, Li R, Jermiin LS. Sensitivity and specificity of information criteria. Brief Bioinform. 2020;21:553鈥65.

    听 听 听

  29. Castel AD, Befus M, Willis S, Griffin A, West T, Hader S, et al. Use of the community viral load as a population-based biomarker of HIV burden. AIDS. 2012;26:345鈥53.

    听 听 听

  30. Chakraborty H, Weissman S, Duffus WA, Hossain A, Varma Samantapudi A, Iyer M, et al. HIV community viral load trends in South Carolina. Int J STD AIDS. 2017;28:265鈥76.

    听 听 听

  31. Touzard Romo F, Gillani FS, Ackerman P, Rana A, Kojic EM, Beckwith CG. Monitored viral load: a measure of HIV treatment outcomes in an outpatient setting in Rhode Island. R I Med J. 2013;2014:98鈥26. 30.

  32. Monno L, Saracino A, Scudeller L, Santoro C, Brindicci G, Punzi G, et al. Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy. HIV Med. 2017;18:711鈥23.

    CAS听 听 听

  33. Jain V, Petersen M, Havlir DV. Population HIV viral load metrics for community health. Lancet HIV. 2021;8:e523鈥4.

    CAS听 听 听

  34. Rozhnova G, Anastasaki M, Kretzschmar M. Modelling the dynamics of population viral load measures under HIV treatment as prevention. Infect Dis Model. 2018;3:160鈥70.

    听 听 听

  35. Farahani M, Radin E, Saito S, Sachathep KK, Hladik W, Voetsch AC, et al. Population viral load, Viremia, and recent HIV-1 infections: findings from Population-based HIV Impact assessments (PHIAs) in Zimbabwe, Malawi, and Zambia. JAIDS J Acquir Immune Defic Syndr. 2021;87:S81鈥8.

    CAS听 听 听

  36. Patel EU, Solomon SS, Lucas GM, McFall AM, Srikrishnan AK, Kumar MS, et al. Temporal change in population-level prevalence of detectable HIV viraemia and its association with HIV incidence in key populations in India: a serial cross-sectional study. Lancet HIV. 2021;8:e544鈥53.

    CAS听 听 听 听

  37. Tanser F, B盲rnighausen T, Dobra A, Sartorius B. Identifying 鈥榗orridors of HIV transmission鈥 in a severely affected rural South African population: a case for a shift toward targeted prevention strategies. Int J Epidemiol. 2018;47:537鈥49.

    听 听 听

  38. Philip NM. Population-level HIV risk and combination implementation of HIV services.

  39. Tomita A, Vandormael A, B盲rnighausen T, Phillips A, Pillay D, De Oliveira T, et al. Sociobehavioral and community predictors of unsuppressed HIV viral load: multilevel results from a hyperendemic rural South African population. AIDS. 2019;33:559鈥69.

    听 听 听

Acknowledgements

The authors thank all the volunteers who participated in the study and all the staff involved in this study from Xinjiang Uighur Autonomous Region Center for Disease Control and Prevention and Yining Center for Disease Control and Prevention.

Funding

This study was supported by the Xinjiang Key Laboratory of HIV/AIDS Prevention and Control Research (No. XJYS1706), National Science and Technology Major Project of the Ministry of Science and Technology of China (No.2018ZX10715-007).

Author information

Authors and Affiliations

Authors

Contributions

QH and YN contributed to the cohort follow-up, data collection, data analysis and manuscript preparation; YL and XH contributed to the study design and conception, experimental work and data collection; XH and ZN contributed to experimental work and sample collection; CZ, BX, and AA contributed to the cohort follow-up work and data analysis; MN contributed to the study design and conception, data analysis and interpretation, and supervised the work. All authors reviewed the manuscript.

Corresponding author

Correspondence to Mingjian Ni.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the AIDS research ethics committee of the Center for Disease Control and Prevention of Xinjiang Uygur Autonomous Region (No. 2018-001). All study procedures were performed in accordance with relevant guidelines. All participants were given an oral explanation of the purpose and content of the study and have provided their written informed consent, for minor research subjects aged 13 to 18 years, the consent process involves a joint decision-making approach between the subjects and their parents or guardians regarding participation. During the consent acquisition phase, a signed informed consent from the parent or guardian was obtained.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher鈥檚 note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 2: Table S1. Sensitivity analysis of missing VL data from 2017 to 2019. Table S2. Comparison of VL monitoring indicators for different populations from 2017 to 2019. Table S3. Correlation analysis of VL monitoring indicators of different population and ART coverage, viral suppression rate and viremia prevalence. Table S4. Comparison of CVL between different ART, viral load suppression and viremia prevalence statuses before and after imputation.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article鈥檚 Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article鈥檚 Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit .

About this article

Cite this article

He, Q., Ni, Y., Li, Y. et al. Association between population viral load surrogate indicator and HIV transmission potential: a prospective cohort study in Xinjiang, China. 樱花视频 25, 128 (2025). https://doi.org/10.1186/s12889-025-21278-6

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-025-21278-6

Keywords